www.brainleague.com

 
 

Indian Patent Office (IPO) has been conferred the status of International Search Authority (ISA) and International Preliminary Examination Authority(IPEA) under Patent Cooperation Treaty (PCT).

Issue: February 2008
 
 

PRESS ROOM

MTS settles patent dispute with Cobra

Mobile Traffic Systems Corporation (MTS), a subsidiary of Acacia Research Corporation filed a patent infringement case on April 11, 2007 in Alabama Northern District Court against Cobra Electronics Corp., Garmin USA, Inc., Magellan Navigation, Inc. and TomTom, Inc. for infringing two patents delivering real time traffic information through GPS navigation system. MTS finally settled the patent litigation with Cobra Electronics Corp. on 4 February, 2008. The settlement includes a license agreement between the two companies over the use of the impugned patents. However the other three companies have decided to continue with the patent infringement case. 

Legal tussle between Matsushita and Samsung ends

A legal battle between Japan’s Matsushita Electric Industrial Co., the maker of the Panasonic brand of products and South Korea’s Samsung Electronics Co. started with a lawsuit filed by the former in the New Jersey court in January, 2002 which led to a row of cases over the years. The lawsuits involved patents regarding semiconductors. The long running legal tussle ended with a settlement between the two companies in US and Japan with a cross-licensing agreement deal for 10 years and the termination of all pending cases between the two companies.

Novartis agrees to supply Glivac for free

Novartis has agreed to supply the cancer drug, Glivac, to a certain number of patients in Thailand for free under the Glivec International Patient Assistance Programme. The drug will be made available under a State Health Program of Thailand under which forty three million patients are covered. The drug will be given to about nine hundred cancer patients belonging to the lower income group. In response, the Thailand government has agreed to restrain from granting a compulsory license on the patent held by Novartis over Glivac.

 

London Agreement comes into force

On grant of an European patent, certain countries require a translation into official languages of such countries in order to give effect to the patent. The London Agreement, or as put formally, the Agreement on the application of Article 65 of the Convention on the Grant of European Patents was concluded in London on October 17, 2000 to reduce the high costs involved in such translation.

The agreement provides that each country has to choose one of the three official language of the European Patent Office i.e. English, French or German for translation to make a european patent effective in that country. As per the agreement, any country will have the right to require translation of the claims in one of its official language. In case of patent litigation, a country can require a translation to be provided in one of the official languages of the country.

The agreement had to be ratified by the UK, Germany and France to make it effective. Germany and the UK had ratified it long ago but France had been holding the same for quite a while. Finally, on 29 January 2008, the instruments of ratification was deposited by France and the agreement shall now enter into force on 1 May 2008. It is estimated that the agreement will reduce the cost of translation for getting patents in Europe by about forty percent.  

Copyright © Brain League IP Services Pvt. Ltd. 2007
You can now access IP related research papers, white papers, opinion papers, case briefs and more on our website. Register for free at www.brainleague.com/researchpaper.htm
We welcome your observations and comments on
contact@brainleague.com